Study identifies predictors of poor outcomes in Duchenne muscular dystrophy patients – Gears Of Biz
|
Study identifies predictors of poor outcomes in Duchenne muscular dystrophy patients
Gears Of Biz Using the new gene-editing enzyme CRISPR–Cpf1, researchers from the Olson Laboratory successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab. The UT Southwestern group had previously used CRISPR-Cas9, the original … |
